Clinical Trial

MIRA Pharmaceuticals Showcases Significant Progress and Announces Final Phase of Regulatory Work as It Prepares for IND Submission by Year-End

MIAMI, FL / ACCESSWIRE / August 19, 2024 / MIRA Pharmaceuticals Inc. (NASDAQ:MIRA) "MIRA" or the "Company"), a leading pre-clinical-stage…

1 year ago

MindBio Announces Sustained Antidepressant Response 3-Months Post Treatment in Microdosing Depression Clinical Trials

Three months post cessation of an 8-week course of microdosing treatment, the antidepressant response is sustained with a 62.8% reduction…

1 year ago

UPDATE: Sol-Gel Reports Second Quarter 2024 Financial Results and Provides Corporate Updates

Following recent transactions and cost-cutting efforts, Sol-Gel’s cash runway is expected to extend into the first quarter of 2026Ongoing Phase…

1 year ago

Bavarian Nordic Provides Statement on Mpox Vaccine Supply and Collaboration with African and Global Stakeholders

COPENHAGEN, Denmark, August 17, 2024 – Bavarian Nordic A/S (OMX: BAVA) provides an update on plans for securing supply of…

1 year ago

Audax Private Equity to Acquire Avantor’s Clinical Services Business

SAN FRANCISCO & BOSTON--(BUSINESS WIRE)--Audax Private Equity (“Audax”) announced today it has entered into a definitive agreement to acquire the…

1 year ago

CodaMetrix’s AI Platform Now Available in Epic Toolbox to Transform $20B Medical Coding Sector

CodaMetrix’s AI platform, developed with and used by 20 top U.S. health systems, efficiently and accurately transforms patient records into…

1 year ago

Results From European Randomized Controlled Study Using XVIVO’s Heart Technology Published in The Lancet

GOTHENBURG, SWEDEN / ACCESSWIRE / August 16, 2024 / XVIVO Perfusion AB (STO:XVIVO)(LSE:0RKL)(FRA:3XV) Today, the results of the European randomized…

1 year ago

Genmab Announces Changes to its Executive Committee

Media Release COPENHAGEN, Denmark; August 16, 2024 Rayne Waller joins as Executive Vice President and Chief Technology OfficerBrad Bailey appointed…

1 year ago

Safety Shot Releases Second Quarter 2024 Results and Corporate Highlights

- Q2 Revenues Increased 40%- Q2 Operating Expenses Decreased 17.7%- Recent Clinical Trial Confirms Dramatic Reduction of Blood Alcohol Content-…

1 year ago